(Q43270473)

17 November 2017

CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients (English)

1 reference

17 November 2017

0 references

Wei Zhang

1

1 reference

17 November 2017

Yan-Zi Chang

2

1 reference

17 November 2017

Quan-Cheng Kan

3

1 reference

17 November 2017

Li-Rong Zhang

4

1 reference

17 November 2017

Zhi-Song Li

5

1 reference

17 November 2017

Hui Lu

6

1 reference

17 November 2017

Zhong-Yu Wang

7

1 reference

17 November 2017

Qin-Jun Chu

8

1 reference

17 November 2017

Jie Zhang

9

1 reference

17 November 2017

26 September 2009

1 reference

European Journal of Clinical Pharmacology

17 November 2017

1 reference

17 November 2017

66

1 reference

17 November 2017

1

1 reference

17 November 2017

61-66

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-009-0726-4

17 November 2017

0 references

cites work

Pharmacogenomics as molecular autopsy for forensic toxicology: genotyping cytochrome P450 3A4*1B and 3A5*3 for 25 fentanyl cases

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-009-0726-4

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

21 January 2018

1 reference

12 December 2020

Prediction of cyclosporine clearance in liver transplant recipients by the use of midazolam as a cytochrome P450 3A probe.

1 reference

12 December 2020

Differences in CYP3A41G genotype distribution and haplotypes of CYP3A4, CYP3A5 and CYP3A7 in 3 Chinese populations

1 reference

12 December 2020

Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population.

1 reference

12 December 2020

Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate

1 reference

12 December 2020

Haplotypes of CYP3A4 and their close linkage with CYP3A5 haplotypes in a Japanese population.

1 reference

12 December 2020

The minimum effective concentration of opioids: a revisitation with patient controlled analgesia fentanyl

1 reference

12 December 2020

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

1 reference

12 December 2020

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

1 reference

12 December 2020

Cytochrome P-450 3A4: regulation and role in drug metabolism

1 reference

12 December 2020

In vitro and in vivo drug interactions involving human CYP3A.

1 reference

12 December 2020

The distribution and gender difference of CYP3A activity in Chinese subjects

1 reference

12 December 2020

Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.

1 reference

12 December 2020

Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography-mass spectrometry

1 reference

12 December 2020

Patient-controlled analgesia

1 reference

12 December 2020

Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.

1 reference

12 December 2020

Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain

1 reference

12 December 2020

CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin

1 reference

12 December 2020

Association of CYP3A4*18B polymorphisms with the pharmacokinetics of cyclosporine in healthy subjects

1 reference

12 December 2020

Pharmacogenomics--drug disposition, drug targets, and side effects

1 reference

12 December 2020

10.1007/S00228-009-0726-4

Identifiers

DOI

1 reference

17 November 2017

1 reference